Literature DB >> 17344356

Molecular epidemiology of Staphylococcus saprophyticus isolated from women with uncomplicated community-acquired urinary tract infection.

Micael Widerström1, Johan Wiström, Sven Ferry, Carina Karlsson, Tor Monsen.   

Abstract

Staphylococcus saprophyticus is a common cause of urinary tract infections (UTIs) in women. Little is known about the molecular epidemiology of S. saprophyticus UTIs. In the current study, we compared 76 isolates of S. saprophyticus prospectively isolated from women with uncomplicated UTI participating in a randomized placebo-controlled treatment trial performed in northern Sweden from 1995 to 1997 with 50 strains obtained in 2006 from five different locations in northern Europe with pulsed-field gel electrophoresis (PFGE). The aim was to elucidate the molecular epidemiology of this uropathogenic species and to investigate whether specific clones are associated with UTI in women. A total of 47 different PFGE profiles were detected among the 126 analyzed isolates. Ten clusters consisting of 5 to 12 isolates each showing PFGE DNA similarity of >85% were identified. Several clusters of genetically highly related isolates were detected in the original trial as well as among isolates obtained during 2006 from different locations. In the original trial, clonal persistence was found among 16 of 21 (76%) patients examined in the placebo group at follow-up 8 to 10 days after inclusion, indicating a low spontaneous short-time bacteriological cure rate. We conclude that multiple clones of S. saprophyticus were causing lower UTIs in women. The result suggests that some human-pathogenic clones of S. saprophyticus are spread over large geographical distances and that such clones may persist over long periods of time.

Entities:  

Mesh:

Year:  2007        PMID: 17344356      PMCID: PMC1865898          DOI: 10.1128/JCM.02071-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems.

Authors:  M. J. Struelens
Journal:  Clin Microbiol Infect       Date:  1996-08       Impact factor: 8.067

2.  Clonal spread of staphylococci among patients with peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  T Monsen; C Olofsson; M Rönnmark; J Wiström
Journal:  Kidney Int       Date:  2000-02       Impact factor: 10.612

3.  An inexpensive and reliable method for routine identification of staphylococcal species.

Authors:  T Monsen; M Rönnmark; C Olofsson; J Wiström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

4.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Staphylococcus saprophyticus found to be a common contaminant of food.

Authors:  P Hedman; O Ringertz; B Eriksson; P Kvarnfors; M Andersson; L Bengtsson; K Olsson
Journal:  J Infect       Date:  1990-07       Impact factor: 6.072

7.  Staphylococcus saprophyticus urinary tract infections: epidemiological data from Western Australia.

Authors:  P F Schneider; T V Riley
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

8.  Urinary tract infection in primary health care in northern Sweden. I. Epidemiology.

Authors:  S Ferry; L G Burman; B Mattsson
Journal:  Scand J Prim Health Care       Date:  1987-05       Impact factor: 2.581

9.  The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study.

Authors:  Sven A Ferry; Stig E Holm; Hans Stenlund; Rolf Lundholm; Tor J Monsen
Journal:  Scand J Infect Dis       Date:  2004

10.  Colonization of the female genital tract with Staphylococcus saprophyticus.

Authors:  M E Rupp; D E Soper; G L Archer
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

View more
  14 in total

1.  Using MALDI-TOF MS typing method to decipher outbreak: the case of Staphylococcus saprophyticus causing urinary tract infections (UTIs) in Marseille, France.

Authors:  K D Mlaga; G Dubourg; C Abat; H Chaudet; L Lotte; S M Diene; D Raoult; R Ruimy; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-22       Impact factor: 3.267

Review 2.  Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus.

Authors:  M Widerström; J Wiström; A Sjöstedt; T Monsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

3.  Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.

Authors:  Masato Higashide; Makoto Kuroda; Carlos Takashi Neves Omura; Miyuki Kumano; Saburo Ohkawa; Sadahiro Ichimura; Toshiko Ohta
Journal:  Antimicrob Agents Chemother       Date:  2008-03-24       Impact factor: 5.191

4.  Sporadic compared to recurrent urinary tract infections: Considerations for urogynecologic patients.

Authors:  Megan S Bradley; Camila Cabrera; Stephanie Glass Clark; Jessica Sassani; Kristen Venuti; Mary F Ackenbom
Journal:  Neurourol Urodyn       Date:  2020-08-17       Impact factor: 2.696

5.  Staphylococcus saprophyticus Causing Infections in Humans Is Associated with High Resistance to Heavy Metals.

Authors:  Opeyemi U Lawal; Maria J Fraqueza; Peder Worning; Ons Bouchami; Mette D Bartels; Luisa Goncalves; Paulo Paixão; Elsa Goncalves; Cristina Toscano; Joanna Empel; Malgorzata Urbaś; Maria A Domínguez; Henrik Westh; Hermínia de Lencastre; Maria Miragaia
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

6.  A molecular portrait of maternal sepsis from Byzantine Troy.

Authors:  Alison M Devault; Tatum D Mortimer; Andrew Kitchen; Henrike Kiesewetter; Jacob M Enk; G Brian Golding; John Southon; Melanie Kuch; Ana T Duggan; William Aylward; Shea N Gardner; Jonathan E Allen; Andrew M King; Gerard Wright; Makoto Kuroda; Kengo Kato; Derek Eg Briggs; Gino Fornaciari; Edward C Holmes; Hendrik N Poinar; Caitlin S Pepperell
Journal:  Elife       Date:  2017-01-10       Impact factor: 8.140

7.  Adaptation in a Fibronectin Binding Autolysin of Staphylococcus saprophyticus.

Authors:  Tatum D Mortimer; Douglas S Annis; Mary B O'Neill; Lindsey L Bohr; Tracy M Smith; Hendrik N Poinar; Deane F Mosher; Caitlin S Pepperell
Journal:  mSphere       Date:  2017-11-29       Impact factor: 4.389

8.  Coagulase-Negative Staphylococci Clones Are Widely Distributed in the Hospital and Community.

Authors:  Luiza Pinheiro-Hubinger; Danilo Flávio Moraes Riboli; Lígia Maria Abraão; Eliane Patricia Lino Pereira Franchi; Maria de Lourdes Ribeiro de Souza da Cunha
Journal:  Pathogens       Date:  2021-06-23

9.  Time-based distribution of Staphylococcus saprophyticus pulsed field gel-electrophoresis clusters in community-acquired urinary tract infections.

Authors:  Viviane Santos de Sousa; Renata Fernandes Rabello; Rubens Clayton da Silva Dias; Ianick Souto Martins; Luisa Barbosa Gomes da Silva dos Santos; Elisabeth Mendes Alves; Lee Woodford Riley; Beatriz Meurer Moreira
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743

10.  Synergism and the mechanism of action of the combination of α-mangostin isolated from Garcinia mangostana L. and oxacillin against an oxacillin-resistant Staphylococcus saprophyticus.

Authors:  Sineewan Phitaktim; Mullika Chomnawang; Kittipot Sirichaiwetchakoon; Benjawan Dunkhunthod; Glyn Hobbs; Griangsak Eumkeb
Journal:  BMC Microbiol       Date:  2016-08-26       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.